«ÈÌÌÓÍÎÄÈÀÃÍÎÑÒÈ×ÅÑÊÀß ÑÈÑÒÅÌÀ ÄËß ÎÖÅÍÊÈ ÍÀÏÐßÆÅÍÍÎÑÒÈ ÏÎÑÒÂÀÊÖÈÍÀËÜÍÎÃÎ ÈÌÌÓÍÈÒÅÒÀ Ê ÊÎÊËÞØÓ, ÄÈÔÒÅÐÈÈ È ÑÒÎËÁÍßÊÓ ...»

113. O'Keeffe, M. Preliminary evaluation of a lateral flow immunoassay device for screening urine samples for the presence of sulphamethazine / M. O'Keeffe, P.

Crabbe, M. Salden et al. // Journal of Immunological Methods. – 2003. – V.278.

– P. 117–126.

114. Parpia, Z. p24 antigen rapid test for diagnosis of acute pediatric HIV infection / Z.

Parpia, R. Elghanian, A. Nabatiyan et al. // JAIDS. – 2010. – V.55. – P. 413–419.

115. Peel, M. Measurement of tetanus antitoxin II. Toxin neutralization / M. Peel // Journal of Biological Standardization. – 1980. – V. 8. – P. 191–207.

116. Pickering, J. Comparison of a Multiplex Flow Cytometric Assay with Enzyme– Linked Immunosorbent Assay for Quantitation of Antibodies to Tetanus, Diphtheria, and Haemophilus influenzae Type b / J. Pickering, T. Martins, Schroder M. et al. // Clinical and Diagnostic Laboratory Immunology. – 2002. – V.9. – P. 872–876.

117. Pietsch, M. Impfserologie zur Ergnzung von Impfungen / M. Pietsch // Der Allgemeinarzt. – 1993. – V.18.

118. Placido Sousa, C. The Action of Diphtheria Toxin on Tissue Cultures and its Neutralization by Antitoxin / Placido Sousa C., Evans D. // British Journal of Experimental Pathology. – 1957. – V. 38. – P. 644–649.

119. Plikaytis, B. Determination of parallelism and nonparallelism in bioassay dilution curves / B. Plikaytis, P. Holder, L. Pais et al. // Journal of Clinical Microbiology.

—1994. —V.32. — P. 2441–2447.

120. Plotkin, S. Vaccines, 4th Edition / ed by. S. Plotkin, W. Orenstein – Philadelphia:Sanders, 2004. – 1696 p.

121. Posthuma–Trumpie, G. Development of a competitive lateral flow immunoassay for progesterone: Influence of coating conjugates and buffer components / G.

Posthuma–Trumpie, J. Korf, A. Amerongen // Analytical and Bioanalytical Chemistry. – 2008. – V.392. – P. 1215–1223.

122. Posthuma–Trumpie, G. // Amorphous Carbon Nanoparticles: a Versatile Label for Rapid Diagnostic (Immuno)Assays / G. Posthuma–Trumpie, J. Wichers, M. Koets et al. // Analytical and Bioanalytical Chemistry. – 2012. – V. 402. – P. 593–600.

123. Queenan, A. Pertactin–Negative Variants of Bordetella pertussis in the United States / A. Queenan, P. Cassiday, A. Evangelista // New England Journal of Medicine. – 2013. – V.368. – P. 583–584.

124. Rayev, M. Carbon–protein covalent conjugates in noninstrumental immunodiagnostic systems / M. Rayev, K. Shmagel // Journal of Immunological Methods. – 2008. – V.336. – P.9–15.

125. Robbins, J. Toward a new vaccine for pertussis / J. Robbins, R. Schneerson, J.

Kubler–Kielb et al. // Proceedings of the National Academy of Sciences. – 2014. – V. 111.– P. 3213–3216.

126. Saffar, M. Pertussis Resurgence in a Highly Vaccinated Population, Mazandaran, North of Iran: An Epidemiological Analysis / M. Saffar, G. Jafar, Gholamreza et al. // Indian Journal of Pediatrics. – 2014. – V. 81. – P. 1332–1336.

127. Sajid, M. Designs, formats and applications of lateral flow assay: A literature review / M. Sajid, A. Kawde, M. Daud // Journal of Saudi Chemical Society. – 2014.

128. Sako, W. Studies on pertussis immunization / W. Sako // Journal of Pediatrics. – 1947. – V.30. – P. 29–40.

129. Salk, J. Use of color change of phenol red as the indicator in titrating poliomyelitis virus or its antibody in a tissue–culture system / J. Salk, J. Youngner, E. Ward // American Journal of Epidemiology. – 1954. – V. 60. – P. 214–230.

130. Scheibel, I. Duration of Immunity to Diphtheria and Tetanus after Active Immunization / I. Scheibel, M. Bentzon, P. Christensen // Acta pathologica et microbiologica Scandinavica. – 1966. – V.67. – P. 380.

131. Scheifele, D., Ochnio J. The Immunological Basis for Immunization Series:

Diphtheria / D. Scheifele, J. Ochnio. – Geneva: WHO Document Production Services, 2009. – 28 p.

132. Schrder, J. Knowledge–based approach to clinical decision–support system, with an application in tetanus serology / J. Schrder, W. Kuhlmann, C. Trendelenburg // Clinica Chimica Acta. – 1993. – V.222. – P. 79–83.

133. Sedgwick, A. Rapid quantitative microenzyme–linked immunosorbent assay for tetanus antibodies / A. Sedgwick, M. Ballow, K. Sparks et al. // Journal of Clinical Microbiology. – 1983. – V.18. – P. 104–109.

134. Sesardic, D. Targeting of specific domains of diphtheria toxin by site–directed antibodies / D. Sesardic, V. Khan, M. Corbel // Microbiology. – 1992. –V. 138. – ¹10. – P. 2197–2203.

135. Shahin, R. Characterization of the protective capacity and immunogenicity of the 69–kD outer membrane protein of Bordetella pertussis / R. Shahin, M. Brennan, Z.

Li // The Journal of Experimental Medicine. – 1990. – V.171. – P. 63–73.

136. Simonsen, O. ELISA for the routine determination of antitoxic immunity to tetanus / O. Simonsen, M. Bentzon, I. Heron // Journal of Biological Standardization. – 1986. – V. 14. – P. 231–239.

137. Simonsen, O. Modification of the ELISA for the estimation of tetanus antitoxin in human sera / O. Simonsen, C. Schou, I. Heron // Journal of Biological Standardization. – 1987. – V.15. – P. 143–57.

138. Simonsen, O. Vaccination against tetanus and diphtheria. Evaluation of immunity in the Danish population, guidelines for revaccination, and the methods for control of vaccination programmes / O. Simonsen // Danish Medical Bulletin. – 1989. – V.36. – P.24–47.

139. Smits, G. Development of a Bead–Based Multiplex Immunoassay for Simultaneous Quantitative Detection of IgG Serum Antibodies against Measles, Mumps, Rubella, and Varicella–Zoster Virus / G. Smits, P. van Gageldonk, L.

Schouls et al. // Clinical and Vaccine Immunology: CVI. –2012. – 19. – P. 396– 400.

140. Stevenson, L. Parallelism: Considerations for the development, validation and implementation of PK and biomarker ligand–binding assays / L. Stevenson, S.

Purushothama // Bioanalysis. – 2014. – V. 6. – ¹2. – P. 185–198.

141. Stiffler–Rosenberg, G. Measurement of human tetanus antitoxin by enzyme–linked immunosorbent assay (ELISA) / G. Stiffler–Rosenberg, H. Fey // Schweizerische medizinische Wochenschrift. – 1977. – V. 107. – P. 1101–1104.

142. Storsaeter, J. Levels of anti–pertussis antibodies related to protection after household exposure to Bordetella pertussis / J. Storsaeter, H. Hallander, Gustafsson L. et al. // Vaccine. – 1998. – V. 16. – P. 1907–1916.

143. Storsaeter, J. Relative efficacy of two acellular pertussis vaccines during three years of passive surveillance / J. Storsaeter, P. Olin // Vaccine. – 1992. – V. 10. – P. 142–144.

144. Surez–Pantalen, C. Development of an immunochromatographic assay based on carbon nanoparticles for the determination of the phytoregulator forchlorfenuron / C. Surez–Pantalen, J. Wichers, A. Abad–Somovilla et al. // Biosensors and Bioelectronics. – 2013. – V.42. – P. 170–176.

145. Syed, M. Pertussis: A reemerging and an underreported infectious disease / M.

Syed, N. Bana // Saudi Medical Journal. – 2014. – V. 35. – P. 1181–1187.

146. Tate, J. Interferences in Immunoassay / J. Tate, G. Ward // The Clinical Biochemist Reviews. – 2004. – V. 25. – ¹2. – P. 105–120.

147. Tighe, P. ELISA in the multiplex era: Potentials and pitfalls ELISA in the multiplex era: Potentials and pitfalls / P. Tighe, Ryder R., Todd I. et al. // Proteomics Clinical applications. – 2015. – V.9. – P. 406–422.

148. Trollfors, B. A Placebo–Controlled Trial of a Pertussis–Toxoid Vaccine / B.

Trollfors, J. Taranger, T. Lagergård et al. // New England Journal of Medicine. – 1995. – V. 333. – P. 1045–1050.

149. van Amerongen, A. Colloidal carbon particles as a new label for rapid immunochemical test methods: Quantitative computer image analysis of results / A. van Amerongen, J. Wichers, L. Berendsen et al. // Journal of Biotechnology. – 1993. – V.30. – P.185–195.

150. van Dam, J. Diagnosis of Schistosomiasis by Reagent Strip Test for Detection of Circulating Cathodic Antigen G / J. van Dam, J. Wichers, T. Falcao Ferreira et al.

// Journal of Clinical Microbiology. – 2004. – V.42. – P. 5458–5461.

151. van Gageldonk, P. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus / P. van Gageldonk, F. van Schaijk, F. van der Klis et al. // Journal of Immunological Methods. – 2008. – V. 335. – P. 79–89.

152. Walory, J. Comparison of four serological methods for the detection of diphtheria anti–toxin antibody / J. Walory, P. Grzesiowski, W. Hryniewicz // Journal of Immunological Methods. – 2000. – V. 245. – ¹1–2. – P. 55–65

153. Weisglas–Kuperus, N. Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in Dutch preschool children / N. Weisglas– Kuperus, S. Patandin, G. Berbers et al. // Environmental Health Perspectives. – 2000. – V. 108. – P. 1203.

154. WHO. Weekly epidemiological record [Ýëåêòðîííûé ðåñóðñ]. – 2006. – No20. –

– Ðåæèì äîñòóïà:

P.198–208.

http://www.who.int/immunization/wer8120tetanus_May06_position_paper.pdf

155. Wild, D. The Immunoassay handbook / D. Wild, J. Rhys, C. Sheehan et al. – Oxford: Elsevier, 2013. – 1013 p.

156. Wills, G. Pgp3 Antibody Enzyme–Linked Immunosorbent Assay, a Sensitive and Specific Assay for Seroepidemiological Analysis of Chlamydia trachomatis Infection / G. Wills, P. Horner, R. Reynolds et al. // Clinical and Vaccine Immunology: CVI. – 2009. – V. 16. – ¹6. – P. 835–843.

157. Wilson, A. Development and Evaluation of a Blocking Enzyme–Linked Immunosorbent Assay and Virus Neutralization Assay To Detect Antibodies to Viral Hemorrhagic Septicemia Virus. A. Wilson, T. Goldberg, S. Marcquenski et al // Clinical and Vaccine Immunology: CVI. – 2014. – V. 21. – ¹3. – P. 435– 442.

158. Wilson, D. Fifth–generation digital immunoassay for prostate–specific antigen by single molecule array technology / D. Wilson, W. Hanlon, G. Provuncher et al. // Clinical Chemistry. – 2011. – V.57. – P. 1712–1721.

159. Xu, H. The selection of ELISA cut–off points for testing antibody to Newcastle disease by two–graph receiver operating characteristic (TG–ROC) analysis / H. Xu, J. Lohr, M. Greiner // Journal of Immunological Methods. – 1997. – V. 208. – ¹1.

– P. 61–64

160. Xu, Y. Seroprevalence of pertussis in China: Need to improve vaccination strategies. / Y. Xu, L.Wang, J. Xu et al. // Human Vaccines & Immunotherapeutics.

– 2014. – V.10. – P.192–198.

161. Yang, H. Evaluation of Parallelism Test Methods Using ROC Analysis / H. Yang, L. Zhang // Statistics in Biopharmaceutical Research. – 2012. – V.4. – P.162–173.

162. Youden, W. Index for rating diagnostic tests / W. Youden // Cancer. – 1950. – V.

3. – ¹1. – P. 32–35.

163. Zackrisson, G. History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin / G.

Zackrisson, J. Taranger, B. Trollfors // The Journal of Pediatrics. – 1990. – V.116.

– P.190–194.

164. Zweig, M. Receiver–operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine / M. Zweig, G. Campbell // Clinical Chemistry.

– 1993. – V.39 – P. 561–577.